Vor Biopharma (VOR) Other Non-Current Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Other Non-Current Assets data on file, last reported at $2.4 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $2.4 million, up 1.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 1.65% YoY), and the FY2025 annual result was $2.4 million, changed 0.04% from the prior year.
• Other Non-Current Assets advanced to $2.4 million in Q1 2026 per VOR's latest filing, from $2.4 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $8.2 million in Q1 2022 and troughed at $269000.0 in Q3 2025.
• A 5-year average of $3.1 million and a median of $2.8 million in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 217.16% in 2022, then sank 89.29% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $2.9 million in 2022, then jumped by 64.51% to $4.8 million in 2023, then plunged by 50.48% to $2.4 million in 2024, then rose by 0.04% to $2.4 million in 2025, then grew by 1.01% to $2.4 million in 2026.
• Business Quant data shows VOR's Other Non-Current Assets at $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $269000.0 in Q3 2025.